Literature DB >> 27977645

Preliminary Report of Microcephaly Potentially Associated with Zika Virus Infection During Pregnancy - Colombia, January-November 2016.

Esther Liliana Cuevas, Van T Tong, Nathaly Rozo, Diana Valencia, Oscar Pacheco, Suzanne M Gilboa, Marcela Mercado, Christina M Renquist, Maritza González, Elizabeth C Ailes, Carolina Duarte, Valerie Godoshian, Christina L Sancken, Angelica Maria Rico Turca, Dinorah L Calles, Martha Ayala, Paula Morgan, Erika Natalia Tolosa Perez, Hernan Quijada Bonilla, Ruben Caceres Gomez, Ana Carolina Estupiñan, Maria Luz Gunturiz, Dana Meaney-Delman, Denise J Jamieson, Margaret A Honein, Martha Lucia Ospina Martínez.   

Abstract

In Colombia, approximately 105,000 suspected cases of Zika virus disease (diagnosed based on clinical symptoms, regardless of laboratory confirmation) were reported during August 9, 2015-November 12, 2016, including nearly 20,000 in pregnant women (1,2). Zika virus infection during pregnancy is a known cause of microcephaly and serious congenital brain abnormalities and has been associated with other birth defects related to central nervous system damage (3). Colombia's Instituto Nacional de Salud (INS) maintains national surveillance for birth defects, including microcephaly and other central nervous system defects. This report provides preliminary information on cases of congenital microcephaly identified in Colombia during epidemiologic weeks 5-45 (January 31-November 12) in 2016. During this period, 476 cases of microcephaly were reported, compared with 110 cases reported during the same period in 2015. The temporal association between reported Zika virus infections and the occurrence of microcephaly, with the peak number of reported microcephaly cases occurring approximately 24 weeks after the peak of the Zika virus disease outbreak, provides evidence suggesting that the period of highest risk is during the first trimester of pregnancy and early in the second trimester of pregnancy. Microcephaly prevalence increased more than fourfold overall during the study period, from 2.1 per 10,000 live births in 2015 to 9.6 in 2016. Ongoing population-based birth defects surveillance is essential for monitoring the impact of Zika virus infection during pregnancy on birth defects prevalence and measuring the success in preventing Zika virus infection and its consequences, including microcephaly.

Entities:  

Mesh:

Year:  2016        PMID: 27977645     DOI: 10.15585/mmwr.mm6549e1

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  48 in total

1.  Better surveillance to protect mothers and infants from Zika.

Authors:  Suzanne M Gilboa; Christopher J Gregory; Margaret A Honein
Journal:  Lancet Infect Dis       Date:  2019-10       Impact factor: 25.071

2.  A Possible Link Between Pyriproxyfen and Microcephaly.

Authors:  Raphael Parens; H Frederik Nijhout; Alfredo Morales; Felipe Xavier Costa; Yaneer Bar-Yam
Journal:  PLoS Curr       Date:  2017-11-27

Review 3.  Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network.

Authors:  Matthew T Aliota; Leda Bassit; Shelton S Bradrick; Bryan Cox; Mariano A Garcia-Blanco; Christina Gavegnano; Thomas C Friedrich; Thaddeus G Golos; Diane E Griffin; Andrew D Haddow; Esper G Kallas; Uriel Kitron; Marc Lecuit; Diogo M Magnani; Caroline Marrs; Natalia Mercer; Edward McSweegan; Lisa F P Ng; David H O'Connor; Jorge E Osorio; Guilherme S Ribeiro; Michael Ricciardi; Shannan L Rossi; George Saade; Raymond F Schinazi; Geraldine O Schott-Lerner; Chao Shan; Pei-Yong Shi; David I Watkins; Nikos Vasilakis; Scott C Weaver
Journal:  Antiviral Res       Date:  2017-06-06       Impact factor: 5.970

4.  Sequential Neuroimaging of the Fetus and Newborn With In Utero Zika Virus Exposure.

Authors:  Sarah B Mulkey; Dorothy I Bulas; Gilbert Vezina; Yamil Fourzali; Armando Morales; Margarita Arroyave-Wessel; Christopher B Swisher; Caitlin Cristante; Stephanie M Russo; Liliana Encinales; Nelly Pacheco; Youssef A Kousa; Robert S Lanciotti; Carlos Cure; Roberta L DeBiasi; Adre J du Plessis
Journal:  JAMA Pediatr       Date:  2019-01-01       Impact factor: 16.193

5.  Reducing Unintended Pregnancies as a Strategy to Avert Zika-Related Microcephaly Births in the United States: A Simulation Study.

Authors:  Katherine A Ahrens; Jennifer A Hutcheon; Loretta Gavin; Susan Moskosky
Journal:  Matern Child Health J       Date:  2017-05

Review 6.  Vaccination strategies against Zika virus.

Authors:  Estefania Fernandez; Michael S Diamond
Journal:  Curr Opin Virol       Date:  2017-04-19       Impact factor: 7.090

7.  Zika Virus Disease and Pregnancy Outcomes in Colombia.

Authors:  Martha L Ospina; Van T Tong; Maritza Gonzalez; Diana Valencia; Marcela Mercado; Suzanne M Gilboa; Andrea J Rodriguez; Sarah C Tinker; Angelica Rico; Christina M Winfield; Lissethe Pardo; Jennifer D Thomas; Greace Avila; Julie M Villanueva; Sara Gomez; Denise J Jamieson; Franklyn Prieto; Dana Meaney-Delman; Oscar Pacheco; Margaret A Honein
Journal:  N Engl J Med       Date:  2020-08-06       Impact factor: 91.245

8.  Addressing Children's Needs in Disasters: A Regional Pediatric Tabletop Exercise.

Authors:  Sarita Chung; Aaron H Gardner; David J Schonfeld; Jessica L Franks; Marvin So; Eric J Dziuban; Georgina Peacock
Journal:  Disaster Med Public Health Prep       Date:  2018-01-15       Impact factor: 1.385

9.  Etiology of Microcephaly and Central Nervous System Defects during the Zika Epidemic in Colombia.

Authors:  Romeo R Galang; Greace Alejandra Avila; Diana Valencia; Marcela Daza; Van T Tong; Antonio José Bermúdez; Suzanne M Gilboa; Angélica Rico; Jordan Cates; Oscar Pacheco; Christina M Winfield; Franklyn Prieto; Margaret A Honein; Liliana J Cortés; Cynthia A Moore; Martha L Ospina
Journal:  J Pediatr       Date:  2020-05-13       Impact factor: 4.406

10.  Zika virus infection causes widespread damage to the inner ear.

Authors:  Kathleen T Yee; Biswas Neupane; Fengwei Bai; Douglas E Vetter
Journal:  Hear Res       Date:  2020-06-29       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.